494 related articles for article (PubMed ID: 18381476)
1. Validity of four self-reported colorectal cancer screening modalities in a general population: differences over time and by intervention assignment.
Jones RM; Mongin SJ; Lazovich D; Church TR; Yeazel MW
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):777-84. PubMed ID: 18381476
[TBL] [Abstract][Full Text] [Related]
2. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
3. Validation of self-reported history of colorectal cancer screening.
Khoja S; McGregor SE; Hilsden RJ
Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
[TBL] [Abstract][Full Text] [Related]
4. Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter?
Vernon SW; Tiro JA; Vojvodic RW; Coan S; Diamond PM; Greisinger A; Fernandez ME
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):758-67. PubMed ID: 18381467
[TBL] [Abstract][Full Text] [Related]
5. Measuring the quality of colorectal cancer screening: the importance of follow-up.
Etzioni DA; Yano EM; Rubenstein LV; Lee ML; Ko CY; Brook RH; Parkerton PH; Asch SM
Dis Colon Rectum; 2006 Jul; 49(7):1002-10. PubMed ID: 16673056
[TBL] [Abstract][Full Text] [Related]
6. Validity of self-reported colorectal cancer screening behavior.
Baier M; Calonge N; Cutter G; McClatchey M; Schoentgen S; Hines S; Marcus A; Ahnen D
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):229-32. PubMed ID: 10698488
[TBL] [Abstract][Full Text] [Related]
7. Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases.
Bastani R; Glenn BA; Maxwell AE; Ganz PA; Mojica CM; Chang LC
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):791-8. PubMed ID: 18381469
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening adherence in a general population.
Yeazel MW; Church TR; Jones RM; Kochevar LK; Watt GD; Cordes JE; Engelhard D; Mongin SJ
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):654-7. PubMed ID: 15066933
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer screening in Massachusetts: measuring compliance with current guidelines.
Erban S; Zapka J; Puleo E; Vickers-Lahti M
Eff Clin Pract; 2001; 4(1):10-7. PubMed ID: 11234181
[TBL] [Abstract][Full Text] [Related]
10. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer test use--Maryland, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Sep; 56(36):932-6. PubMed ID: 17851446
[TBL] [Abstract][Full Text] [Related]
12. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
El-Serag HB; Petersen L; Hampel H; Richardson P; Cooper G
Arch Intern Med; 2006 Nov; 166(20):2202-8. PubMed ID: 17101937
[TBL] [Abstract][Full Text] [Related]
13. Are gender differences in colorectal cancer screening rates due to differences in self-reporting?
Griffin JM; Burgess D; Vernon SW; Friedemann-Sanchez G; Powell A; van Ryn M; Halek K; Noorbaloochi S; Grill J; Bloomfield H; Partin M
Prev Med; 2009 Nov; 49(5):436-41. PubMed ID: 19765609
[TBL] [Abstract][Full Text] [Related]
14. Measuring complete diagnostic evaluation in colorectal cancer screening.
Myers RE; Fishbein G; Hyslop T; Hauck WW; Kutch M; Grana JR; Schlackman N
Cancer Detect Prev; 2001; 25(2):174-82. PubMed ID: 11341353
[TBL] [Abstract][Full Text] [Related]
15. Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.
Myers RE; Turner B; Weinberg D; Hauck WW; Hyslop T; Brigham T; Rothermel T; Grana J; Schlackman N
Prev Med; 2001 Oct; 33(4):249-60. PubMed ID: 11570828
[TBL] [Abstract][Full Text] [Related]
16. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
17. Validity of self-reported endoscopies of the large bowel and implications for estimates of colorectal cancer risk.
Hoffmeister M; Chang-Claude J; Brenner H
Am J Epidemiol; 2007 Jul; 166(2):130-6. PubMed ID: 17456475
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
[TBL] [Abstract][Full Text] [Related]
19. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.
Schroy PC; Geller AC; Crosier Wood M; Page M; Sutherland L; Holm LJ; Heeren T
Prev Med; 2001 Nov; 33(5):381-91. PubMed ID: 11676578
[TBL] [Abstract][Full Text] [Related]
20. Colorectal carcinoma screening procedure use among primary care patients.
Lafata JE; Williams LK; Ben-Menachem T; Moon C; Divine G
Cancer; 2005 Oct; 104(7):1356-61. PubMed ID: 16092119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
